Peter Johannes Holst

Peter Johannes Holst

Guest Researcher

Member of:

  • EXPVACC/LEV team

ORCID: 0000-0002-1279-304X

Publication year:
All
1 - 2 out of 2Page size: 10
  1. 2015
  2. Published

    Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein

    Salanti, A., Clausen, T. M., Agerbæk, M. Ø., Al Nakouzi, N., Dahlbäck, M., Oo, H. Z., Lee, S., Gustavsson, T., Rich, J. R., Hedberg, B. J., Mao, Y., Barington, L., Pereira, M. A., LoBello, J., Endo, M., Fazli, L., Soden, J., Wang, C. K., Sander, A. F., Dagil, R. & 15 others, Thrane, Susan, Holst, Peter Johannes, Meng, L., Favero, F., Weiss, G. J., Nielsen, Morten Agertoug, Freeth, J., Nielsen, T. O., Zaia, J., Tran, N. L., Trent, J., Babcook, J. S., Theander, Thor Grundtvig, Sorensen, P. H. & Daugaard, M., 2015, In: Cancer Cell. 28, 4, p. 500-14 15 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Targeting of non-dominant antigens as a vaccine strategy to broaden T-cell responses during chronic viral infection

    Holst, Peter Johannes, Jensen, Benjamin Anderschou Holbech, Ragonnaud, Emeline, Thomsen, Allan Randrup & Christensen, Jan Pravsgaard, 2015, In: PLOS ONE. 10, 2, 17 p., e0117242.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 7853